| Wissenschaftl. Titel | A Phase III, Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Glofitamab (RO7082859) in Combination With Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma |
| Erkrankung |
Haema:
NHL: diffuses, großzelliges B-Zell-Lymphom:
Erstlinie
|
| Kurzprotokoll | Kurzprotokoll |
| Links | Weiterführende Informationen (NIH) |
erstellt 18.10.2024 Data entry III CCP
geändert 18.10.2024 Data entry III CCP